Sandbox Cardiovascular Drugs2/Antihypertensives: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{|class="infobox" style="position: fixed; top: 210px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: | {|class="infobox" style="position: fixed; top: 210px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 25%; background: #104E8B; border-radius: 10px 10px 10px 10px;" | ||
|- | |- | ||
| style="font-weight: bold; font-size: 125%; padding: 5px 5px; text-align: center; background: #104E8B; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" | [[Sandbox Cardiovascular Drugs2|{{Fontcolor|#F8F8FF|Cardiovascular Drugs}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antiarrhythmics|{{Fontcolor|#F8F8FF|Antiarrhythmics}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Antihypertensives|{{Fontcolor|#F8F8FF|Antihypertensives}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antithrombotics|{{Fontcolor|#F8F8FF|Antithrombotics}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Beta Blockers|{{Fontcolor|#F8F8FF|Beta Blockers}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Lipid-Modifying Agents|{{Fontcolor|#F8F8FF|Lipid-Modifying Agents}}]] | |||
|- | |- | ||
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Renin-Angiotensin System Inhibitors|{{Fontcolor|#F8F8FF|Renin-Angiotensin System Inhibitors}}]] | |||
|- | |- | ||
! style="font-size: | ! style="margin: 50px 50px; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Vasodilators|{{Fontcolor|#F8F8FF|Vasodilators}}]] | ||
|} | |} | ||
<div style="width: 75%;"> | |||
content here | |||
</div> |